Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin with or without ZD4054 in metastatic breast cancer
ISRCTN73466214Phase 2Terminated
- Sponsor
- Cardiff University
- Start
- Jun 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of zibotentan and carboplatin in breast cancer (4 arms), sponsored by Cardiff University. Primary endpoint: Progression-free survival. Started Jun 2010; status: terminated.
02
Drugs
zibotentancarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN73466214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73466214.